ProCE Banner Activity

Applying the Clinical Rationale for Inhibiting the Complement-Mediated Hemolysis in CAD

Slideset

Downloadable slideset with the latest clinical data for targeting the complement pathway as a successful strategy for the management of patients with CAD, including clinical data updates and expanded indication for anti-C1 targeted agent sutimlimab.

Released: December 01, 2023

Share

Faculty

Catherine M. Broome

Catherine M. Broome, MD

Professor of Medicine
Division of Hematology/Oncology
MedStar Georgetown University Hospital
Washington, DC

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi